Kinepict Health Kft

OUR MISSION IS TO MAKE X-RAY ANGIOGRAPHY SAFER AND MORE POWERFUL!

OUR VISION IS 10-FOLD REDUCTION IN X-RAY AND 5-FOLD REDUCTION OR ELIMINATION OF IODINATED CONTRAST MEDIA

Kinepict Health Ltd. was founded in 2015 and rose as a result of 20+ years of research. So far our team has completed several clinical studies validating our patented Digital Variance Angiography (DVA) technology, published peer-reviewed papers in leading radiology journals to prove the benefits of DVA. This technology is integrated into the Kinepict Medical Imaging Tool (KMIT) which is a CE marked and FDA approved class IIa medical device software and fully complies with ISO 13485 standard. KMIT has provided safer and faster interventions for more than 5000 patients so far in our reference site network in Europe.

Kinepict’s DVA technology has at least 3 fundamental and unique benefits, addressing clear unmet medical needs: DVA drastically enhances the quality of the images (3-10 times higher signal-to-noise ratio) and using this quality reserve reduces the x-ray exposure by at least 70% and ICM dose by at least 50% in angiographic interventions.

Unique selling points:

Safer and powerful platform for patients in cath labs in hospitals/ clinics:

• Reduced risk of complications from radiation exposure for patients. It enables longer procedures to treat obese and high-risk patients. Reduce x-ray radiation by 70%: reducing the cases of cancer associated with X-ray radiation and long-term health risk for physicians and staff worldwide

• Improve outcomes in patients with Chronic Kidney Disease by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs

• Suitable for pregnant women and patients with impaired kidney function

Improved performance for CO2 angiography:

• Better image quality in CO2 angiography than the industry standard DSA

• First platform that improves image quality and reduce radiation in CO2 angiography

Faster operation:

• Reduce the number of DSA runs needed to obtain a good image

• More accurate imaging improves patient outcome, contributing to a better life quality and a longer life expectancy and reducing the mortality

• Faster diagnosis and shorter intervention → accelerated work-flow in the healthcare sector

Cost-effective and efficient platform:

• Reduce the cost associated with the reduction of ICM dose by 50% and the need of repetitions of the angiogram due to lack of quality

• Reduce the cost of every cath lab: save € 220,000 €/year in operational costs (considering €165,000: reduced procedural time €55,000: ICM saving

• Reduce the cost of €329,000/ year in the healthcare system

• Dose management: reduce radiation and ICM dose

• Reduce the workflow in hospitals and it will be evaluated internationally

Compatibility with angiography equipment:

• Independent platform that improves the quality of the angiography equipment from medical imaging companies (e.g. Siemens, Philips)

User-friendly for doctors and patients:

• The physicist will receive a training about the use of the platform, the highly automated operation does not require to extensive training

•Patients do not need extra collaboration, everything is identical with the current procedures.